You are about to leave the Clinical Value website now.


Hepatocellular Carcinoma Surveillance: Challenging the status quo

Roche Diagnostics Australia hosted an information evening dedicated to exploring the current diagnostic tools and management criteria of liver cancer, also known as hepatocellular carcinoma (HCC), in Australia.

Secondary care clinicians (specialists) such as gastroenterologists, hepatologists, and oncologists from across Australia were invited to a thought-provoking HCC surveillance educational event in Melbourne.

In this engaging session, three Australian liver cancer experts shed light on the current standard of care in Australia, HCC surveillance strategies, and blood-based biomarkers to assist in early diagnosis.

Watch the highlight video and full presentation video here.

You May Also Like

27 June 2024

The implications of identifying and managing HCC surveillance patients in General Practice

Read More
14 June 2024

Empowering Healthcare Professionals to Combat Liver Cancer in Australia

Read More


Be the first to receive updates, event opportunities, and thought leadership insights.